Loading cancer entity…
Loading cancer entity…
Clinical trials
55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01275586 | Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas | completed | Early Phase 1 | 6 | Indiana UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01567787 | Proton Radiation Therapy for Spinal Tumors(NF01) | withdrawn | N/A | 0 | University of FloridaOTHER | 0 | Feb 10, 2017 | clinicaltrials |
| NCT00716469 | Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas(PDT) | terminated | Phase 1 | 7 | Children's Hospital of PhiladelphiaOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01412892 |
Data updated 22 days agoSource updated Apr 12, 2017source: clinicaltrials
| completed |
| Phase 2 |
| 30 |
| Assistance Publique - Hôpitaux de ParisOTHER |
| 1 |
| Nov 14, 2014 |
| clinicaltrials |
| NCT01031901 | Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) | completed | Phase 1 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 27, 2012 | clinicaltrials |